pith. sign in

arxiv: 2606.02877 · v1 · pith:SNDNEDB4new · submitted 2026-06-01 · 💻 cs.CV

Pathway-Structured Privileged Distillation for Deployable Computational Pathology

Yongxin Guo , Hao Lu , Onur Koyun , Zhengjie Zhu , Muhammet Demir , Metin Gurcan This is my paper

Pith reviewed 2026-06-28 14:58 UTC · model grok-4.3

classification 💻 cs.CV
keywords privileged distillationmixture of pathway expertscomputational pathologywhole-slide imagestranscriptomicsknowledge distillationbreast cancer
0
0 comments X

The pith

Mixture of Pathway Experts transfers RNA pathway supervision to histology models via memory alignment for better WSI-only inference.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper introduces Mixture of Pathway Experts (MoPE) as a privileged distillation method that encodes RNA-derived pathways and aligns memory usage to pass molecular supervision to image-based pathology experts. This setup is motivated by the fact that whole-slide images can reflect some morphology-linked effects of molecular programmes even though they cannot reconstruct full transcriptomic states. A reader would care because RNA profiling is rarely available in routine clinical workflows while histology slides are standard, so the method lets scarce molecular data improve deployable image-only models. Experiments report consistent gains over baselines on public benchmarks and two breast cancer cohorts together with pathway-usage inspection.

Core claim

MoPE reframes multimodal integration as privileged distillation by encoding RNA-derived pathways and transferring molecular supervision to pathway-indexed pathology experts through memory-usage alignment, yielding improved whole-slide-image-only inference across diverse public benchmarks and two independent breast cancer cohorts while supporting pathway-usage analyses and human-audited visual inspection.

What carries the argument

Mixture of Pathway Experts (MoPE), a set of pathway-indexed pathology experts that receive RNA-derived supervision through memory-usage alignment during training.

If this is right

  • WSI-only inference performance improves consistently relative to baseline methods on public benchmarks and breast cancer cohorts.
  • Pathway-usage analyses supply bounded inspection of which molecular programmes the model draws upon.
  • Human-audited visual inspection yields candidate morphology-linked readouts tied to specific pathways.
  • Molecular information can be used during training while preserving fully RNA-free inference at deployment.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same memory-alignment mechanism could be tested on other privileged data types such as proteomics or spatial transcriptomics.
  • Ablating individual pathways and measuring corresponding drops in specific morphology predictions would test whether the transferred supervision is biologically targeted.
  • The framework implies that partial observability between modalities can be turned into an advantage rather than a limitation when the observable modality is far cheaper to acquire at scale.

Load-bearing premise

Histology images capture morphology-linked consequences of certain molecular programmes so memory-usage alignment can transfer useful supervision without full transcriptomic reconstruction at inference.

What would settle it

No gain or a performance drop in WSI-only accuracy on a new independent cohort when MoPE is compared head-to-head against standard distillation baselines would falsify the claim.

read the original abstract

Integrating transcriptomics and histopathology can improve cancer risk modelling, yet practical use is constrained by the limited availability of RNA profiling in routine settings. Here we introduce Mixture of Pathway Experts (MoPE), a knowledge-distillation framework that reframes multimodal learning as privileged distillation for histology-only inference. MoPE is motivated by the partial observability between RNA profiles and whole-slide images: histology can capture morphology-linked consequences of certain molecular programmes, but cannot be expected to reconstruct the full transcriptomic state. MoPE encodes RNA-derived pathways and transfers the molecular supervision to pathway-indexed pathology experts through memory-usage alignment. Across diverse public benchmarks and two independent breast cancer cohorts, MoPE consistently improved WSI-only inference performance relative to baseline methods. Pathway-usage analyses and human-audited visual inspection provide bounded inspection of model behaviour and candidate morphology-linked readouts. These results support pathway-structured privileged distillation as a promising route to using molecular information during training while preserving RNA-free inference.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

0 major / 1 minor

Summary. The manuscript introduces Mixture of Pathway Experts (MoPE), a knowledge-distillation framework that reframes multimodal learning as privileged distillation. RNA-derived pathways provide molecular supervision to pathway-indexed pathology experts via memory-usage alignment; the resulting model is intended for RNA-free whole-slide image (WSI) inference. The central empirical claim is that MoPE yields consistent performance gains over baseline methods on diverse public benchmarks and two independent breast cancer cohorts, supported by pathway-usage analyses and human-audited visual inspection.

Significance. If the reported gains are reproducible and statistically robust, the work would offer a practical route to incorporating transcriptomic information during training while preserving deployable histology-only inference. The emphasis on bounded, auditable pathway usage is a constructive step toward interpretability in computational pathology.

minor comments (1)
  1. [Abstract] Abstract: the claim of 'consistent improvement' is stated without any numerical results, confidence intervals, baseline specifications, cohort sizes, or statistical tests, preventing quantitative evaluation of the central claim from the provided text.

Simulated Author's Rebuttal

0 responses · 0 unresolved

We thank the referee for their summary of our work on Mixture of Pathway Experts (MoPE) and for noting its potential as a practical route to incorporating transcriptomic supervision during training while enabling RNA-free inference. We are encouraged by the recognition of the bounded, auditable pathway usage as a step toward interpretability. Since no specific major comments were enumerated in the report, we provide no point-by-point responses below. We remain available to address any additional questions the referee may have.

Circularity Check

0 steps flagged

No significant circularity identified

full rationale

The provided abstract and context contain no equations, fitted parameters, derivations, or self-citations that reduce any claimed result to an input by construction. MoPE is presented as a distillation framework motivated by partial observability, with performance gains asserted empirically on external benchmarks and cohorts. No load-bearing step equates a prediction to its own definition or relies on an unverified self-citation chain. The derivation chain is therefore self-contained against the given material.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 0 invented entities

Review performed on abstract alone; no explicit free parameters, axioms, or invented entities can be extracted beyond the core domain assumption stated in the motivation.

axioms (1)
  • domain assumption Histology can capture morphology-linked consequences of certain molecular programmes but cannot reconstruct the full transcriptomic state.
    Explicitly stated as motivation for the partial observability premise in the abstract.

pith-pipeline@v0.9.1-grok · 5709 in / 1161 out tokens · 22610 ms · 2026-06-28T14:58:01.282293+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

58 extracted references · 1 linked inside Pith

  1. [1]

    Campanella, G.et al.Clinical-grade computational pathology using weakly supervised deep learning on whole slide images.Nature medicine25, 1301–1309 (2019)

    2019

  2. [2]

    & Weinberg, R

    Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation.cell 144, 646–674 (2011)

    2011

  3. [3]

    Paik, S.et al.A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.New England Journal of Medicine351, 2817–2826 (2004)

    2004

  4. [4]

    A.et al.Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer.New England Journal of Medicine379, 111–121 (2018)

    Sparano, J. A.et al.Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer.New England Journal of Medicine379, 111–121 (2018)

    2018

  5. [5]

    M.et al.Integration of clinical features and deep learning on pathol- ogy for the prediction of breast cancer recurrence assays and risk of recurrence

    Howard, F. M.et al.Integration of clinical features and deep learning on pathol- ogy for the prediction of breast cancer recurrence assays and risk of recurrence. NPJ Breast Cancer9, 25 (2023)

    2023

  6. [6]

    A.et al.Translating rna sequencing into clinical diagnostics: opportunities and challenges.Nature Reviews Genetics17, 257–271 (2016)

    Byron, S. A.et al.Translating rna sequencing into clinical diagnostics: opportunities and challenges.Nature Reviews Genetics17, 257–271 (2016)

    2016

  7. [7]

    Damodaran, S., Berger, M. F. & Roychowdhury, S. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meetinge175–e182 (2015)

    2015

  8. [8]

    A.et al.Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer.New England journal of medicine380, 2395–2405 (2019)

    Sparano, J. A.et al.Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer.New England journal of medicine380, 2395–2405 (2019). 20

    2019

  9. [9]

    Cardoso, F.et al.70-gene signature as an aid to treatment decisions in early-stage breast cancer.New England Journal of Medicine375, 717–729 (2016)

    2016

  10. [10]

    Coudray, N.et al.Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning.Nature medicine24, 1559–1567 (2018)

    2018

  11. [11]

    N.et al.Pan-cancer image-based detection of clinically actionable genetic alterations.Nature cancer1, 789–799 (2020)

    Kather, J. N.et al.Pan-cancer image-based detection of clinically actionable genetic alterations.Nature cancer1, 789–799 (2020)

    2020

  12. [12]

    Fu, Y.et al.Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis.Nature cancer1, 800–810 (2020)

    2020

  13. [13]

    Schmauch, B.et al.A deep learning model to predict RNA-Seq expression of tumours from whole slide images.Nature communications11, 3877 (2020)

    2020

  14. [14]

    Curtis, C.et al.The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Nature486, 346–352 (2012)

    2012

  15. [15]

    Z.et al.A single-cell and spatially resolved atlas of human breast cancers

    Wu, S. Z.et al.A single-cell and spatially resolved atlas of human breast cancers. Nature genetics53, 1334–1347 (2021)

    2021

  16. [16]

    Danenberg, E.et al.Breast tumor microenvironment structures are associated with genomic features and clinical outcome.Nature genetics54, 660–669 (2022)

    2022

  17. [17]

    & Welling, M

    Ilse, M., Tomczak, J. & Welling, M. Attention-based deep multiple instance learning.International conference on machine learning2127–2136 (2018)

    2018

  18. [18]

    Guo, Y.et al.Bpmambamil: A bio-inspired prototype-guided multiple instance learning for oncotype dx risk assessment in histopathology.Computer Methods and Programs in Biomedicine109039 (2025)

    2025

  19. [19]

    Shao, Z.et al.Transmil: Transformer based correlated multiple instance learning for whole slide image classification.Advances in neural information processing systems34, 2136–2147 (2021)

    2021

  20. [20]

    Shao, D.et al.Mixture of mini experts: Overcoming the linear layer bottleneck in multiple instance learning.arXiv preprint arXiv:2603.22198(2026)

    arXiv 2026

  21. [21]

    Chen, R. J.et al.Pathomic fusion: an integrated framework for fusing histopathol- ogy and genomic features for cancer diagnosis and prognosis.IEEE transactions on medical imaging41, 757–770 (2020)

    2020

  22. [22]

    Chen, R. J.et al.Multimodal co-attention transformer for survival prediction in gigapixel whole slide images.Proceedings of the IEEE/CVF International Conference on Computer Vision (ICCV)4015–4025 (2021). 21

    2021

  23. [23]

    & Chen, H

    Xu, Y. & Chen, H. Multimodal optimal transport-based co-attention trans- former with global structure consistency for survival prediction.Proceedings of the IEEE/CVF international conference on computer vision21241–21251 (2023)

    2023

  24. [24]

    H.et al.Multimodal prototyping for cancer survival prediction.arXiv preprint arXiv:2407.00224(2024)

    Song, A. H.et al.Multimodal prototyping for cancer survival prediction.arXiv preprint arXiv:2407.00224(2024)

    arXiv 2024

  25. [25]

    IEEE Transactions on Pattern Analysis and Machine Intelligence(2025)

    Yan, R.et al.Pathway-aware multimodal transformer (PAMT): Integrating pathological image and gene expression for interpretable cancer survival analysis. IEEE Transactions on Pattern Analysis and Machine Intelligence(2025)

    2025

  26. [26]

    & Dean, J

    Hinton, G., Vinyals, O. & Dean, J. Distilling the knowledge in a neural network. arXiv preprint arXiv:1503.02531(2015)

    Pith/arXiv arXiv 2015

  27. [27]

    Guo, Y.et al.Momentum memory for knowledge distillation in computational pathology.arXiv preprint arXiv:2602.21395(2026)

    arXiv 2026

  28. [28]

    & Yuan, Y

    Xing, X., Zhu, M., Chen, Z. & Yuan, Y. Comprehensive learning and adap- tive teaching: Distilling multi-modal knowledge for pathological glioma grading. Medical image analysis91, 102990 (2024)

    2024

  29. [29]

    Wang, Z.et al.Histo-genomic knowledge association for cancer prognosis from histopathology whole slide images.IEEE Transactions on Medical Imaging44, 2170–2181 (2025)

    2025

  30. [30]

    Zhang, Q.et al.Multi-modal knowledge decomposition based online distillation for biomarker prediction in breast cancer histopathology.International Confer- ence on Medical Image Computing and Computer-Assisted Intervention353–363 (2025)

    2025

  31. [31]

    Zhang, Y., Wang, X., Liu, A., Yu, L. & Li, C. Disentangled multi-modal learning of histology and transcriptomics for cancer characterization.IEEE Transactions on Medical Imaging(2026)

    2026

  32. [32]

    Cell systems1, 417–425 (2015)

    Liberzon, A.et al.The molecular signatures database hallmark gene set collection. Cell systems1, 417–425 (2015)

    2015

  33. [33]

    Lu, H.et al.Classification-based pathway analysis using GPNet with novel p- value computation.Briefings in Bioinformatics26, bbaf039 (2025)

    2025

  34. [34]

    B., Dabbs, D

    Flanagan, M. B., Dabbs, D. J., Brufsky, A. M., Beriwal, S. & Bhargava, R. Histopathologic variables predict Oncotype DX™recurrence score.Modern Pathology21, 1255–1261 (2008)

    2008

  35. [35]

    E.et al.Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.Modern Pathology26, 658–664 (2013)

    Klein, M. E.et al.Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.Modern Pathology26, 658–664 (2013). 22

    2013

  36. [36]

    M., Bentley, R

    Geradts, J., Bean, S. M., Bentley, R. C. & Barry, W. T. The oncotype dx recur- rence score is correlated with a composite index including routinely reported pathobiologic features.Cancer Investigation28, 969–977 (2010)

    2010

  37. [37]

    Adebayo, J.et al.Sanity checks for saliency maps.Advances in neural information processing systems31(2018)

    2018

  38. [38]

    & Wallace, B

    Jain, S. & Wallace, B. C. Attention is not explanation.Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers) 3543–3556 (2019)

    2019

  39. [39]

    Andani, S.et al.Histopathology-based protein multiplex generation using deep learning.Nature Machine Intelligence7, 1292–1307 (2025)

    2025

  40. [40]

    D., Solon, M

    Webster, J. D., Solon, M. & Gibson-Corley, K. N. Validating immunohisto- chemistry assay specificity in investigative studies: considerations for a weight of evidence approach.Veterinary pathology58, 829–840 (2021)

    2021

  41. [41]

    M´ ear, L.et al.Transcriptomics and spatial proteomics for discovery and valida- tion of missing proteins in the human ovary.Journal of Proteome Research23, 238–248 (2023)

    2023

  42. [42]

    J.et al.Towards a general-purpose foundation model for computational pathology.Nature medicine30, 850–862 (2024)

    Chen, R. J.et al.Towards a general-purpose foundation model for computational pathology.Nature medicine30, 850–862 (2024)

    2024

  43. [43]

    J.et al.Lora: Low-rank adaptation of large language models.Iclr1, 3 (2022)

    Hu, E. J.et al.Lora: Low-rank adaptation of large language models.Iclr1, 3 (2022)

    2022

  44. [44]

    Vector quantization.IEEE Assp Magazine1, 4–29 (1984)

    Gray, R. Vector quantization.IEEE Assp Magazine1, 4–29 (1984)

    1984

  45. [45]

    J.et al.Visualizing and interpreting cancer genomics data via the xena platform.Nature biotechnology38, 675–678 (2020)

    Goldman, M. J.et al.Visualizing and interpreting cancer genomics data via the xena platform.Nature biotechnology38, 675–678 (2020)

    2020

  46. [46]

    Subramanian, A.et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proceedings of the national academy of sciences102, 15545–15550 (2005)

    2005

  47. [47]

    Liberzon, A.et al.Molecular signatures database (msigdb) 3.0.Bioinformatics 27, 1739–1740 (2011)

    2011

  48. [48]

    Goyal, M.et al.A multi-model approach integrating whole-slide imaging and clinicopathologic features to predict breast cancer recurrence risk.NPJ Breast Cancer10, 93 (2024)

    2024

  49. [49]

    & Hochreiter, S

    Klambauer, G., Unterthiner, T., Mayr, A. & Hochreiter, S. Self-normalizing neural networks.Advances in neural information processing systems30(2017). 23

    2017

  50. [50]

    & Eliceiri, K

    Li, B., Li, Y. & Eliceiri, K. W. Dual-stream multiple instance learning network for whole slide image classification with self-supervised contrastive learning.Proceed- ings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition 14318–14328 (2021)

    2021

  51. [51]

    Zhang, H.et al.DTFD-MIL: Double-tier feature distillation multiple instance learning for histopathology whole slide image classification.Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition18802– 18812 (2022)

    2022

  52. [52]

    Shao, Z.et al.TransMIL: Transformer based Correlated Multiple Instance Learning for Whole Slide Image Classification.Advances in Neural Information Processing Systems34, 2136–2147 (2021)

    2021

  53. [53]

    Li, J.et al.Dynamic Graph Representation with Knowledge-Aware Attention for Histopathology Whole Slide Image Analysis.2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR)11323–11332 (2024)

    2024

  54. [54]

    Zhang, Q.et al.Multi-modal Knowledge Decomposition based Online Distillation for Biomarker Prediction in Breast Cancer Histopathology.arXiv preprint(2025)

    2025

  55. [55]

    H.et al.Multimodal prototyping for cancer survival prediction.Proceed- ings of the 41st International Conference on Machine Learning235, 46050–46073 (2024)

    Song, A. H.et al.Multimodal prototyping for cancer survival prediction.Proceed- ings of the 41st International Conference on Machine Learning235, 46050–46073 (2024)

    2024

  56. [56]

    URL https://arxiv.org/abs/2503.09496

    Zhou, J.et al.Robust multimodal survival prediction with the latent differ- entiation conditional variational autoencoder.arXiv preprint(2025). URL https://arxiv.org/abs/2503.09496

    arXiv 2025

  57. [57]

    & Mahmood, F

    Zhang, A., Jaume, G., Vaidya, A., Ding, T. & Mahmood, F. Accelerating data processing and benchmarking of ai models for pathology.arXiv preprint arXiv:2502.06750(2025)

    arXiv 2025

  58. [58]

    J.et al.Towards a general-purpose foundation model for computational pathology.Nature Medicine30, 850–862 (2024)

    Chen, R. J.et al.Towards a general-purpose foundation model for computational pathology.Nature Medicine30, 850–862 (2024). 24 a. Clinical motivation (i) (ii) b. Model training workflow Patches … … 𝐸2 𝐸50 𝐸1 Gated Aggregation Linear Biomarker Classification Angiogenesis Glycolysis … Inflammatory Hallmark 50 Pathways × Pathway Tokens Gradient stop Pathway-i...

    2024